Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dries Renmans

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Expert Review of Vaccines|September 30, 2014
The ReNAissanCe of mRNA-based cancer therapySandra Van Lint, Dries Renmans, Katrijn Broos, et al.
Oncotarget|April 15, 2017
Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracersKatrijn Broos, Marleen Keyaerts, Quentin Lecocq, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
Adjuvant-Enhanced mRNA VaccinesLukasz Bialkowski, Kevin Van der Jeught, Dries Renmans, et al.
International Journal of Cancer|February 22, 2018
Immune checkpoint blockade combined with IL-6 and TGF-β inhibition improves the therapeutic outcome of mRNA-based immunotherapyLukasz Bialkowski, Kevin Van der Jeught, Sanne Bevers, et al.
Oncoimmunology|July 3, 2015
Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma modelStephanie Du Four, Sarah K Maenhout, Kari De Pierre, et al.
Oncotarget|February 16, 2015
Targeting the tumor microenvironment to enhance antitumor immune responsesKevin Van der Jeught, Lukasz Bialkowski, Lidia Daszkiewicz, et al.
Scientific Reports|March 3, 2016
Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumoursLukasz Bialkowski, Alexia van Weijnen, Kevin Van der Jeught, et al.
Cancer Immunology Research|December 15, 2015
Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic CellsSandra Van Lint, Dries Renmans, Katrijn Broos, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Review of Vaccines|September 30, 2014
The ReNAissanCe of mRNA-based cancer therapySandra Van Lint, Dries Renmans, Katrijn Broos, et al.
Oncotarget|April 15, 2017
Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracersKatrijn Broos, Marleen Keyaerts, Quentin Lecocq, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
Adjuvant-Enhanced mRNA VaccinesLukasz Bialkowski, Kevin Van der Jeught, Dries Renmans, et al.
International Journal of Cancer|February 22, 2018
Immune checkpoint blockade combined with IL-6 and TGF-β inhibition improves the therapeutic outcome of mRNA-based immunotherapyLukasz Bialkowski, Kevin Van der Jeught, Sanne Bevers, et al.
Oncoimmunology|July 3, 2015
Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma modelStephanie Du Four, Sarah K Maenhout, Kari De Pierre, et al.
Oncotarget|February 16, 2015
Targeting the tumor microenvironment to enhance antitumor immune responsesKevin Van der Jeught, Lukasz Bialkowski, Lidia Daszkiewicz, et al.
Scientific Reports|March 3, 2016
Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumoursLukasz Bialkowski, Alexia van Weijnen, Kevin Van der Jeught, et al.
Cancer Immunology Research|December 15, 2015
Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic CellsSandra Van Lint, Dries Renmans, Katrijn Broos, et al.
Pageof 1